Development and validation of a chemotherapy tolerance prediction model for Chinese multiple myeloma patients: The TM frailty score

Overview of attention for article published in Frontiers in oncology, January 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 5 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 23,488 followers.

Development and validation of a chemotherapy tolerance prediction model for Chinese multiple myeloma patients: The TM frailty score https://t.co/BprBK68RIy https://t.co/LnAW1PK34l

20 Jan 2023

Reply Repost Favourite

New research: Development and validation of a chemotherapy tolerance prediction model for Chinese multiple myeloma patients: The TM frailty score: Objective The physical fitness of older individuals is heterogeneous, making it difficult to… https://t.co/y

20 Jan 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.